UNSPSC 51373202: Tapentadol

This classification denotes an analgesic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H8A007M585. European Medicines Agency schedules Tapentadol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31821. Tapentadol generally arises in the molecular formula C14H23NO. The term TAPENTADOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, no. 2, 2003, list 49.) Most nations schedule tapentadol under HS 29222900 and SITC 51462.

As of Q4 2014, TAPENTADOL remains the US FDA Preferred Term for this commodity. Tapentadol bears US NLM identifiers UMLS ID C2001271 and NCI Concept Code C72139. SMILES: C1=CC=C(C=C1)SCC(CC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)Cl)C(=O)O.

UNSPSC 51373202 Tapentadol is a Commodity code that does not match the state and local procurement activity currently posted under it. The sole recent opportunity on record — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023 — solicits Naloxone and Safe Drug Deactivation Systems for community health initiatives, not tapentadol or other opioid pain medications. Naloxone is a standalone pharmaceutical product used for opioid overdose reversal and falls outside the scope of a tapentadol-specific commodity code. The mismatch suggests either miscoding by the issuing body or an automated classification error in the source data.

The code shows minimal recent activity relevant to its stated purpose. No state or local solicitations for tapentadol itself appear in the available opportunities block. Tapentadol procurement by state and local entities — typically through corrections departments, public health agencies, or hospital systems — may occur under different commodity codes, through statewide pharmaceutical purchasing cooperatives, or via direct negotiation with manufacturers and distributors rather than competitive bidding. Business development professionals should monitor for tapentadol opportunities under related pharmaceutical commodity codes or contact state corrections and health procurement offices directly to identify actual demand signals.